The summary of existing evidence on immunohistochemical markers supplemented with our own data highlighted a differential diagnostic role for AMACR, CK34βE12, CK7, β-Catenin, CD15, and CEA (Table 2) which can be helpful in the routine differential diagnostic workup of adenocarcinomas in the bladder. This evidence concerns the gene AMACR and adenocarcinoma.